To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
When a patient hears the words, “You have breast cancer,” they need to know that all breast cancer is not alike. We will, therefore, recommend a "personalized treatment plan" tailored to their particular disease to maximize the benefit. Since coming to Rutgers Cancer Institute of New Jersey in 1995, I have helped countless patients navigate this journey through a comprehensive approach within our Breast Oncology Program -- because it truly does take a team approach to tackle this disease. Following a fellowship at the Dana Farber Cancer Center at Harvard Medical School, preceded by a residency at the University of Pittsburgh, my expertise has long been breast cancer and breast cancer genetics – including helping people understand their risk of developing breast cancer.
Through the years, I have also been involved in the design and implementation of clinical trials that offer promising new therapies targeted to specific types of breast cancer. With consultation from experts across multiple disciplines, I help educate patients about clinical trial options. With the unique relationship offered through a National Cancer Institute-designated Comprehensive Cancer Center, I have the opportunity to work collaboratively with scientific investigators -- helping to translate information from the patient bedside back to the laboratory. As a professor of medicine at Robert Wood Johnson Medical School, I also enjoy teaching the next generation of oncologists and provide opportunities for students to learn cancer biology, cancer pharmacology, genetics and clinical care.
I am the author or co-author of more than 50 publications and serve on the editorial board of the journal Clinical Cancer Research, one of the nation’s premier cancer publications. As a core member for the Breast Committee of the Eastern Cooperative Oncology Group, which is one of the nation's largest clinical cancer research organizations that conducts clinical trials in all types of adult cancers, I help to develop and identify the next generation of treatment options for women and men with breast cancer.
August 2, 2024
Very good experience.
July 3, 2024
Dr. Toppmeyer is beyond excellent!
May 22, 2024
Very Thorough
April 19, 2024
The respect and gratitude I have for Dr. D. Toppmeyer and her staff is beyond belief. They have been a true lifeline during my cancer treatment. They are extremely knowledgeable, compassionate practitioners. Always honest with me & family - the best professionals I've dealt with.
March 19, 2024
Dr. Toppmeyer is wonderful. She knows my issues regarding health, and she also takes a personal interest in my life. I love her.
March 17, 2024
Very good
March 8, 2024
All good!
February 21, 2024
Dr. D. Toppmeyer is an excellent physician.
January 31, 2024
I wouldn't trade Dr. Toppmeyer for anything. She saved my life!
January 27, 2024
Excellent care since the beginning of my diagnosis.
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.
Deborah Toppmeyer, MD, Chief Medical Officer and Director of both the Breast Oncology Program and LIFE Center at Rutgers Cancer Institute of New Jersey discusses her philosophy of patient care. Watch here
NJ Docs Looking for More Ways to Fight Triple-Negative Breast Cancer
Dr. Toppmeyer spoke with NJ 101.5 about the fight against triple-negative breast cancer. Read more